Question

Post Marketing Surveillance (PMS)

07 Sep 2024
Answer :
Word Count : 626

Post-Marketing Surveillance (PMS) in Drugs Regulatory Affairs refers to the monitoring of a pharmaceutical product's safety, efficacy, and quality after it has been released to the market. This process is crucial for ensuring ongoing patient safety and public health by detecting any adverse effects, rare side effects, or long-term risks that were not identified during the pre-marketing clinical trials. 

### Key Aspects of Post-Marketing Surveillance:

1. Purpose: The primary goal of PMS is to continuously assess the safety and efficacy of drugs in a real-world setting. PMS helps to identify unexpected adverse drug reactions (ADRs), interactions with other drugs, and potential issues related to drug misuse, abuse, or off-label use.

2. Methods: PMS involves various activities, including:
   - Spontaneous Reporting Systems: Healthcare professionals ___ _____ ____ ____ ___ ____ ______.
__________ _______ __________ _________ _______ ______ __________ _____ ___ ___ __________ _____.
_________ _______ ______ _______ _______ ___.
_____ __________ _______ _________ _________ ______ __________ _______ ________ ______ _____.
____ ________ __________ ______ _______.
______ _____ _______ _______ ______ _________ ________ ________.
_____ __________ ______ _______ ____ __________.
____ ________ ____ _________ ____ ___.
_______ ______ _________ _____ ________ _______ ______ _____.
_____ _______ _____ _________ _________ ___ ____ ________ __________ _________.
_________ ___ _______ ______ ________ ____ ____ _______ _____ _______ _______.
___ _________ ______ ____ __________ ________ ________ ____ ___ __________ ___.
__________ ___ ______ _____ ___ _____ _____ __________ _____ __________ _________ ________.
___ ______ __________ _____ _________ ____ _________.
________ _____ _________ _______ _____ _______ _________ ________ _____ _________.
____ ____ ______ ___ ____ ____ ______ _____ _______ _________ ______ __________.
________ _____ ________ ______ _________ _________ _______ ______ _________.
__________ ________ __________ ______ _________ ______ _____ ____ _______ ___ __________.
___ _________ ____ ________ __________ ____ ___ _______ ______ ______ __________.
____ _____ __________ __________ _____ _______.
_________ __________ _________ _______ ___ ___ ______ ______ _________ ______ _______ ___.
__________ _____ _________ ____ _____ ______ __________ _______ ___.
________ _________ _________ _______ __________ ________ _________.
_____ __________ ___ ___ _______ __________ ________ _________ _____ ________ _____.
_________ ___ _________ _____ ____ __________ __________ __________.
___ _____ _______ __________ ______ _____ ______ _______.
____ __________ ________ _____ ________ _______ ____ __________ ___ _______ _______ _____.
___ _________ ____ _________ ______ _______.
___ _____ _______ ______ _________ _________ ______ ________.
________ ____ __________ ________ _____ ________ ____ ___ __________ ____.
______ ____ ___ ___ _____ _____ _________ _______ _________ ______ _____.
______ ____ __________ _________ ____ ____ _____ ______ ___ ___.
______ _______ ____ _____ __________.
___ ____ _____ ________ _______ ____ _________.
__________ _____ ____ ______ __________ ____ _______.
___ ________ _____ ___ __________ ____ _________ _____ ______ ________ ___.
__________ ____ _______ ________ ___.
_________ _____ ______ ________ _____ _________ ___ __________ ________.
_____ __________ _______ __________ __________ ____ __________ _____ ____ ______ ___.
________ _______ __________ _________ ______ ________ _________ ___ ________ _______ ________.
_________ _________ ______ _____ _________ ________ ____ ___.
_________ _____ _______ ____ ___ _____ ______ ______ __________.
__________ __________ ____ ________ ___ _______ ___.
__________ ______ _____ ______ ______ ____ _____ ____.
______ ___ ___ ___ _____ ______ ___ _____ _______ _______ ______ ______.
_______ ________ ________ _____ _____ __________ _________ ___ ______.
____ __________ _____ ____ __________ __________ ______ _________ __________.
__________ ___ _____ _________ ____ ________ ______ ________ ___ _________ __________ _______.
_________ ________ __________ _________ ___.
_________ ___ ______ ____ ______ ______ _____ ___ _________ _______ ____ __________.
_____ _____ _______ __________ ___ ______ _________ ______ ____.
__________ ___ _______ ____ ______ ______ ________ _______.
_______ _________ ____ _________ ______ ______ ______ _________ ______ ____ _____ ________.
____ _________ _______ _______ ________ _____ _____.
____ ________ ____ ____ _______ __________ __________ _______ ________ ________ _____.
_________ __________ ________ ______ ____ _______.
Get Full Answer on WhatsApp

IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance Post Marketing Surveillance (PMS)
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→